ロード中...
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
BACKGROUND: Imatinib mesylate is an effective treatment for metastatic gastrointestinal stromal tumor (GIST). However, most patients eventually develop resistance and there are few other treatment options. Immunotherapy using genetically modified or designer T cells (dTc) has gained increased attent...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3599052/ https://ncbi.nlm.nih.gov/pubmed/23433424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-46 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|